Literature DB >> 33280251

Keratin 1: A Negative Regulator of Inflammation and Potential Treatment for Pulmonary Arterial Hypertension.

Jennifer Trittmann1.   

Abstract

This study by Zhang et al. entitled "Keratin 1 attenuates hypoxic pulmonary artery hypertension through suppressing pulmonary artery media smooth muscle expansion" is presented in a recent edition of Acta Physiologica [1]. Leading up to this research were at least three key ideas: 1) that keratin 1 (Krt1) is considered the gatekeeper of the skin's innate immune response for its important regulatory role of both local and systemic inflammation [2], 2) that inflammation is central to the pathogenesis of pulmonary arterial hypertension (PAH) [3], and 3) that keratins can promote apoptosis of smooth muscle cells derived from human atherosclerotic lesions [4]. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2020        PMID: 33280251     DOI: 10.1111/apha.13594

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  1 in total

Review 1.  Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension.

Authors:  Adrija Hajra; Israel Safiriyu; Prasanth Balasubramanian; Rahul Gupta; Selia Chowdhury; Abhishek J Prasad; Akshay Kumar; Deepak Kumar; Baseer Khan; Roberta S F Bilberry; Ankit Sarkar; Paras Malik; Wilbert S Aronow
Journal:  Curr Probl Cardiol       Date:  2022-04-29       Impact factor: 16.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.